메뉴 건너뛰기




Volumn 31, Issue 5, 2008, Pages 500-502

Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; ERYTHROMYCIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

EID: 41949086364     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.01.012     Document Type: Letter
Times cited : (5)

References (10)
  • 1
    • 0002559431 scopus 로고
    • Epidemiology of Campylobacter jejuni infections in the United States and other industrialised nations
    • Nachamkin I., Blase M., and Tompkins L.S. (Eds), American Society for Microbiology, Washington, DC
    • Tauxe R.J. Epidemiology of Campylobacter jejuni infections in the United States and other industrialised nations. In: Nachamkin I., Blase M., and Tompkins L.S. (Eds). Campylobacter jejuni: current status and future trends (1992), American Society for Microbiology, Washington, DC
    • (1992) Campylobacter jejuni: current status and future trends
    • Tauxe, R.J.1
  • 2
    • 33847045214 scopus 로고    scopus 로고
    • Mutant selection window hypothesis updated
    • Drlica K., and Zhao X. Mutant selection window hypothesis updated. Clin Infect Dis 44 (2007) 681-688
    • (2007) Clin Infect Dis , vol.44 , pp. 681-688
    • Drlica, K.1    Zhao, X.2
  • 3
    • 41949128944 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 2nd ed. Approved standard M31-A2. Wayne, PA: NCCLS; 2002.
    • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 2nd ed. Approved standard M31-A2. Wayne, PA: NCCLS; 2002.
  • 4
    • 33845879085 scopus 로고    scopus 로고
    • Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa
    • Pasquali F., and Manfreda G. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Vet Microbiol 119 (2007) 304-310
    • (2007) Vet Microbiol , vol.119 , pp. 304-310
    • Pasquali, F.1    Manfreda, G.2
  • 5
    • 0032851201 scopus 로고    scopus 로고
    • Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis
    • Zirnstein G., Li Y., Swaminathan B., and Angulo F. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. J Clin Microbiol 37 (1999) 3276-3280
    • (1999) J Clin Microbiol , vol.37 , pp. 3276-3280
    • Zirnstein, G.1    Li, Y.2    Swaminathan, B.3    Angulo, F.4
  • 6
    • 41949092823 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. M100-S14. Wayne, PA: NCCLS; 2004.
    • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. M100-S14. Wayne, PA: NCCLS; 2004.
  • 7
    • 0036927114 scopus 로고    scopus 로고
    • Selection and characterisation of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin
    • Payot S., Cloeckaert A., and Chaslus-Dancla E. Selection and characterisation of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb Drug Resist 8 (2002) 335-343
    • (2002) Microb Drug Resist , vol.8 , pp. 335-343
    • Payot, S.1    Cloeckaert, A.2    Chaslus-Dancla, E.3
  • 8
    • 0027373305 scopus 로고
    • Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers
    • Israel D., Gillum J.G., Turik M., Harvey K., Ford J., Dalton H., et al. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers. Antimicrob Agents Chemother 37 (1993) 2193-2199
    • (1993) Antimicrob Agents Chemother , vol.37 , pp. 2193-2199
    • Israel, D.1    Gillum, J.G.2    Turik, M.3    Harvey, K.4    Ford, J.5    Dalton, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.